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leading to progressive aortic dilatation and, eventu-
ally, rupture. The two major structural elements of
the aortic wall are collagens and elastin, the struc-
tural properties of which are regarded as mutually
complementary. Elastin provides the aortic wall with
distensibility, whereas collagens are responsible for
its tensile strength. Therefore, it has been suggested
that the degradation of arterial elastin seen in
aneurysms leads to vessel dilatation and decreased
distensibility, whereas the degradation of fibrillar
collagens results in decreased tensile strength and
vessel rupture. Thus, the critical element in both the
enlargement and the rupture of the aneurysms may
reside in collagens.3,4
The fibrillar collagen network of the abdominal
aorta consists predominantly of type I and III colla-
gens, the extensile characteristics being attributed to
Aneurysm formation is a complex remodeling
process that involves both synthesis and degradation
of the proteins of the extracellular matrix.1,2
Abdominal aortic aneurysms (AAAs) are character-
ized by structural deterioration of the aortic wall
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Purpose: This study aimed to characterize the distribution of structural domains of type
I and III collagens in the wall of abdominal aortic aneurysms (AAAs), by the use of
undilated atherosclerotic aortas (aortoiliac occlusive disease [AOD]) and healthy
abdominal aortas as controls.
Methods: Immunohistochemical staining was applied with antibodies for the aminoter-
minal propeptides of type I (PINP) and type III (PIIINP) procollagens, which represent
newly synthesized type I and III pN-collagens. In addition, an antibody against the
aminoterminal telopeptide of type III collagen (IIINTP) was used as a means of detect-
ing maturely cross-linked type III collagen fibrils.
Results: The newly synthesized type III procollagen detected by means of PIIINP stain-
ing was concentrated in the media in aneurysmal aortas, whereas type I pN-collagen was
localized in the intima in both AAAs and AODs. The healthy aortas showed no
immunoreactivity for either PIIINP or PINP. The cross-linked type III collagen,
detected by means of IIINTP staining, stained transmurally in all study groups, but
appeared more abundant in the media in AAAs.
Conclusion: Our results strongly suggest that the metabolism of type III collagen is
enhanced in AAAs. Intensive type III pN-collagen staining was present mainly in the
media layer in AAAs, suggesting a role of type III collagen in aneurysm formation,
whereas type I pN-collagen was present in the intima in both AAAs and AODs, sug-
gesting that type I collagen synthesis is a fibroproliferative response related to the ath-
erosclerotic process. The increased type III pN-collagen in AAAs may result in impaired
fibril formation and, thus, in decreased tensile strength of aneurysmal tissue. (J Vasc
Surg 2000;32:1201-7.)
type III collagen.5 Collagens are continually synthe-
sized throughout life, and the collagen content in
the vessel wall thus reflects the net effects of synthe-
sis and degradation.
Type I and III collagens are synthesized and
secreted into the extracellular space as procollagens,
with large extra parts known as propeptides at both
ends.6 The changes in collagen turnover can be fol-
lowed easily by measuring the concentrations of cir-
culating procollagen propeptides.7 We have
previously shown that the metabolism of type III
collagen is accelerated in AAA tissue, a conclusion
based on measuring the aminoterminal propeptide
of type III procollagen (PIIINP) in blood.8,9
In the current study, we used specific antibod-
ies against different structural domains of the main
aortic fibrillar collagens. The stainings for the
aminoterminal propeptides, PINP and PIIINP,
represent the newly synthesized type I and type III
pN-collagens, respectively, with these propeptides
still attached. Between the propeptides and the
helical collagen molecule, there are short non–
triple-helical telopeptides containing the sites for
intermolecular cross-linking. A structure called
IIINTP represents the aminoterminal cross-linked
telopeptide of type III collagen, and, thus, the
third antibody, the one against IIINTP, recognizes
old, already cross-linked and fully matured type III
collagen fibers. We characterized the distribution
of these structural domains of collagens in the walls
of AAAs, in aortoiliac occlusive disease (AOD), and
in healthy aortas.
PATIENTS AND METHODS
Full-thickness longitudinal strips of the anterior
wall of the infrarenal aorta were obtained from 19
consecutive patients (15 men and 4 women; mean
age, 69 years; range, 59-79 years) who underwent
elective aortic reconstruction for degenerative AAAs
at the Department of Surgery, Oulu University
Hospital. All the aneurysms were degenerative and
fusiform, and their maximum diameters had been
measured preoperatively by means of ultrasound
scan (mean diameter, 5.2 cm; range, 4.3-6.4 cm).
The aneurysm specimens were compared with those
from the abdominal aorta of nine cadavers (6 men
and 3 women; mean age, 54 years; range, 40-71
years) with AOD. Among the general demographic
data, there were no significant differences between
the two groups (AAA vs AOD: diabetes mellitus, 5
of 19 vs 3 of 9; coronary artery disease, 11 of 19 vs
6 of 9; chronic obstructive pulmonary disease, 8 of
19 vs 4 of 9; hypertension, 10 of 19 vs 5 of 9). Two
control specimens were obtained from the abdomi-
nal aortas of two cadavers (16 and 61 years). The
control subjects had no symptomatic vascular dis-
ease, and this information was supported by the
absence of significant pathologic vascular changes at
autopsy. All autopsies were performed within 24
hours of death. All specimens were formalin-fixed
and paraffin-embedded. The collection of tissue
samples was approved by the local ethics committee.
Monospecific, polyclonal antibodies against the
aminoterminal propeptides of type I (PINP) and
type III (PIIINP) procollagens and the aminotermi-
nal telopeptide of type III collagen (IIINTP) were
used. The PINP10 and PIIINP11 antigens were puri-
fied from the ascitic fluid of patients with malignant
tumors, and the IIINTP antigen12 was purified from
human uterine leiomyoma. The antisera were raised
in rabbits and purified by means of immunoaffinity
chromatography with cross-adsorption on several
columns with the possible cross-reacting human
extracellular matrix antigens (PINP, PIIINP,
IIINTP, ICTP, 7S domain of type IV collagen,
and/or P1 domain of laminin) and, finally, with the
antigen (PINP, PIIINP, or IIINTP) used in the
immunization coupled to CNBr-activated Sepharose
4B. The lack of cross-reaction was confirmed by
showing that the antibodies did not bind any of sev-
eral radioactively labeled test antigens (eg, no bind-
ing of PIIINP-I125 by the anti-PINP antibodies).
The avidin-biotin-peroxidase method was used
for the immunostainings. Sections 5 µm thick were
deparaffinized and incubated in a solution containing
0.14 g trypsin and 0.1 g CaCl2 in 100 mL of 0.2
mol/L ammonium bicarbonate, pH 7.8, for 40 min-
utes at 37°C. After the trypsin pretreatment, the
slides were washed in phosphate-buffered saline, and
the specific rabbit antihuman antibodies (dilution
1:50 for anti-IIINTP, 1:10 for anti-PIIINP, and
1:100 for anti-PINP) were applied on the slides, fol-
lowed by the biotinylated secondary antirabbit anti-
body and the avidin-biotin-peroxidase complex. The
color reaction was developed with diaminobenzidine.
All samples were trypsinized and stained at the same
time. In the control stainings, phosphate-buffered
saline was substituted for the primary antibody.
To identify smooth muscle cells in the medial
layer of the aortic wall in aneurysms, we used com-
mercially available antibodies against smooth muscle
α-actin (Clone 1A4, Sigma Biosciences, St Louis,
Mo) at a dilution of 1 to 1000. The maximal and
minimal diameters of the positively stained layer
were measured with an ocular micrometer.
The collagen staining reactions were evaluated
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separately by two pathologists (Y.S. and J.M.) in a
blinded fashion. There was a statistically significant
association between the evaluations of these two
observers (P = .038, Fisher exact test). The
immunostainings for the different collagen domains
were assessed separately in the intimal, medial, and
adventitial layers in all samples whenever possible.
The staining reactions were semiquantitatively classi-
fied into 4 groups: –, no staining; +, weak staining;
++, moderate staining; and +++, strong staining.
The Fisher exact test was used for statistical analyses;
in the statistical calculations, the staining intensities
were treated as two groups: –, + and ++, +++. In
Table IV, we reduced the staining intensity data into
two groups (A and B) to ease the comparisons
between AAA and AOD.
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Immunohistochemical type I and III collagen staining of abdominal aortic aneurysm (A, B, and C), athero-
sclerotic abdominal aorta (D, E, and F), and healthy abdominal aorta (G, H, and I). A, D, and G, Staining
of type I pN-collagen; B, E, and H, staining of type III pN-collagen; and C, F, and I, staining of cross-linked
type III collagen (original magnification, 10×; hematoxylin counterstain). The brown color in G and H is
blood, not collagen staining.
RESULTS
Type I and III procollagen antigens are present
in the diseased aortic wall. The PINP, PIIINP, and
IIINTP antigens were all detected with variable inten-
sity in the diseased aortas, whereas the healthy aortas
showed staining only for IIINTP. This is understand-
able, because the aminoterminal propeptides detected
by means of anti-PINP and anti-PIIINP are present
on newly synthesized type I and III collagen fibers,
respectively, whereas IIINTP represents the mature,
cross-linked structure of type III collagen. Thus,
increased metabolic activity can be detected by means
of the staining intensity of PINP and PIIINP.
The average diameter (± SD) of the medial layer
as determined by means of the immunostaining for
smooth muscle α-actin in the aneurysmal walls was
365 ± 227 µm, whereas in the atherosclerotic lesions
it was 796 ± 446 µm (P = .004). In the healthy aor-
tic samples, it was 1200 to 1400 µm.
Abdominal aortic aneurysms. A very strong
linear reaction was seen with the anti-PINP in the
intimal layer of AAAs, whereas such staining was
only slight or completely absent in the medial and
adventitial layers (Table I; Figure, A). For PIIINP,
the strongest linear immunostaining was seen in the
medial layer (Figure, B). The reaction was weaker in
the intimal layer (P = .052) and significantly weaker
in the adventitial layer (P = .007; Table II). IIINTP
reactivity was seen as strong diffuse positivity in the
adventitial and the medial layers of AAAs. A signifi-
cant difference between the intimal and medial lay-
ers (P = .02; Table III; Figure, C) was revealed by
means of the immunoreactivity.
The differences in immunoreactivity between the
AAA and AOD groups are summarized in Table IV.
All the layers of the aneurysmatic aortic wall showed
stronger staining for PIIINP than did the correspond-
ing areas in the AODs (Table IV). The signal for
PINP, which was very strong in the intimal layer of
AAAs, was only slight or absent in the media. A simi-
lar trend was seen in the atherosclerotic specimens,
although the intimal staining was somewhat weaker
(Table IV). For IIINTP, the difference was only evi-
dent in the medial layer, which again showed more
intense IIINTP staining in the AAAs (Table IV).
Aortoiliac occlusive disease and healthy aorta.
Weak to strong (+ to +++) positivity with anti-PINP
was seen in the intimal layer of the atherosclerotic
undilated aorta (Figure, D). Thus, there was a sig-
nificant difference in the AOD specimens between
the intima and both the media and the adventitia (P
= .03). The PIIINP staining (Figure, E) was weak (–
to +) and the IIINTP staining (Figure, F) was mod-
erate (+,++) transmurally, and no statistically signifi-
cant differences in either PIIINP or IIINTP
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Table I. Intensities of PINP staining in different layers of AAA
PINP*
Staining intensity Intima Media Adventitia
No 0 12 11
Weak 0 5 4
Moderate 5 0 1
Strong 12 0 0
*Number of specimens showing the given staining intensity. In some cases, it was not possible to evaluate the particular layer.
Statistical significance between the layers was calculated by means of the Fisher exact test: intima versus media, P = .0001; intima versus
adventitia, P = .0001; media versus adventitia, P = .48.
Table II. Intensities of PIIINP staining in different layers of AAA
PIIINP*
Staining intensity Intima Media Adventitia
No 1 0 2
Weak 5 1 6
Moderate 4 0 2
Strong 9 17 7
*Number of specimens showing the given staining intensity. In some cases, it was not possible to evaluate the particular layer.
Statistical significance between the layers was calculated by means of the Fisher exact test: intima versus media, P = .05; intima versus
adventitia, P = .27; media versus adventitia, P = .007.
immunoreactivity between the different layers of the
atherosclerotic aortic wall were detected.
The samples of healthy aorta revealed no
immunoreactivity for either PINP (Figure, G) or
PIIINP (Figure, H). There was, however, constant
transmural IIINTP staining (Figure, I).
DISCUSSION
In the pathogenesis of AAA, the fragmentation
and decrease of elastin in the medial layer13 shift the
biomechanical stress in the aortic wall to other struc-
tural elements, collagens in particular. Thus, type III
collagen, with its extensile properties,5 may play a
role in resisting pulse pressure. The current study
gives further support to a role of type III collagen in
AAA pathogenesis, because newly synthesized and
incompletely processed type III pN-collagen was
revealed in the media of the aneurysmal aorta. The
collagen content in AAAs may be maintained or
even increased because of the enhanced rate of col-
lagen synthesis.14,15 However, this new collagen
may have delayed cross-link maturation.
The structures recognized in the tissue by means
of anti-PINP or anti-PIIINP antibodies are collagen
fibers on the surface of which the type I or type III,
respectively, collagen molecules still have the
aminoterminal propeptides uncleaved. Because of
the repeated washings and the trypsin treatment, the
corresponding free propeptides are not likely to be
present in the final tissue specimens.
Newly synthesized type III pN-collagen was
mainly concentrated in the media in the aneurysmal
aortas. The type III pN-collagen is more susceptible
to proteolysis, because the cross-link formation at
the aminoterminus is delayed because of the pres-
ence of the bulky propeptide domain. This is impor-
tant, because there are several reports on the
increased amount of collagen-degrading matrix met-
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Table III. Intensities of IIINTP staining in different layers of AAA
IIINTP*
Staining intensity Intima Media Adventitia
No 1 0 0
Weak 5 0 2
Moderate 3 2 3
Strong 10 16 12
*Number of specimens showing the given staining intensity. In some cases, it was not possible to evaluate the particular layer. 
Statistical significance between the layers was calculated by means of the Fisher exact test: intima versus media, P = .02; intima versus
adventitia, P = .15; media versus adventitia, P = .23.
Table IV. Staining intensities of PINP, PIIINP, and IIINTP in the layers of the aortic wall, and their dif-
ferences between AAAs and AOD
PINP* PIIINP* IIINTP*
AOD AAA AOD AAA AOD AAA
Intima
A 3 0 8 6 5 6
B 4 17 1 13 4 13
P value .017† .006† .2
Media
A 7 17 7 1 6 0
B 0 0 0 17 1 18
P value 1 .00009† .00004†
Adventitia
A 7 15 6 8 3 2
B 0 1 0 9 3 15
P value .7 .03† .09
*Number of specimens showing the given staining intensity. In some cases, it was not possible to evaluate the particular layer.
†Statistically significant P values.
A, No or weak immunoreactivity; B, moderate or strong immunoreactivity.
alloproteinases (MMPs)16-18 and cathepsins19 in
AAA. Interesting new data suggest that the distribu-
tions of MMPs in atherosclerotic and aneurysmal
aortas are different. In AODs, MMPs have been
found on the intimal side of the tunica media,
whereas their preferential location in AAAs is within
the adventitia and on the adventitial side of the
media.20 Thus, the type III collagen in the media of
an aneurysm might be under a more severe prote-
olytic attack than the corresponding area in an ath-
erosclerotic aorta without aneurysmal changes.
Furthermore, the PIIINP remaining attached to the
collagen molecule has the capacity to regulate fibril
diameter.21 Therefore, increased amounts of type III
pN-collagen may leave the fibers thinner and thus
lead to a decrease in tensile strength and to the for-
mation of an AAA. Unfortunately, there is not much
data about the structure and regulation of the type
III procollagen N-proteinase.22 The marked
increase of PINP-staining in the intima in AAA sam-
ples indicates active type I collagen synthesis, proba-
bly caused by the atherosclerotic injury often
associated with AAAs. This is supported by the sim-
ilar finding of PINP immunoreactivity in the AOD
samples. An increase in the rate of type I and type III
collagen synthesis has been found (eg, in ovarian
carcinoma23), although the collagen content of the
tissue is decreased, together with incomplete matu-
ration of collagen cross-linking.24
Accordingly, the PIIINP and IIINTP immuno-
stainings together suggest that the type III collagen
was present in the adventitia in its mature, fully
processed form. None of the aneurysms studied had
ruptured. Thus, the enhanced collagen turnover in
the media, which was seen as increased staining of
type III pN-collagen, could represent the initial or
midterm dilatation process. However, the adventitial
extracellular matrix of the aneurysm must also fail to
enable rupture. After removal of the media, the aor-
tic adventitia seems capable of maintaining the nor-
mal aortic diameter throughout the range of
expected blood pressures.25 For example, aortic
endarterectomy, in which the intima and part of the
media are removed, does not cause aneurysm for-
mation. In a healthy person, even the adventitia may
provide enough mechanical support to prevent
dilatation, but under predisposing circumstances, an
aneurysm would develop. The AAA-related alter-
ations are perhaps first manifested in the medial
layer, and these phenomena serve as a window for
further observations about the progression of the
dilatation seen clinically. Our previous investigations
into the evident increase of PIIINP in patient
serum8,9 together with the current study suggest
that the PIIINP antigen also found in blood reflects
the metabolic situation in AAA tissue and thus
strengthens the idea of the usefulness of the PIIINP
assay as an indicator of the aneurysmatic process in
clinical practice.
The AODs were positive for IIINTP but not for
PIIINP, indicating that type III collagen undergoes
full processing into its mature, cross-linked forms and
that the half-life of type III collagen may be longer
and its turnover slower than that of AAA. This find-
ing and the nonexistent differences between the lay-
ers of the aortic wall in AOD samples are consistent
with the idea of metabolic inertia in silent atheroscle-
rotic lesions, such as in carotid plaques, in which we
have previously found the type I and III collagens to
be fully cross-linked and the amount of type III pN-
collagen to be negligible.12 Thus, it seems that there
is enough time in atherosclerosis for complete colla-
gen maturation and processing, whereas in AAAs the
demand for repair exceeds the proper processing of
collagen molecules. Not only the increased amount
of type III pN-collagen, but also the defects in the
synthesized collagen might result in impaired fibril
formation, because mutations in the type III collagen
gene have been found in patients with a familial ten-
dency to AAAs.26,27
Our results are in accordance with the idea that
the synthesis of type III collagen is enhanced in
AAAs. Furthermore, the newly synthesized type III
collagen was present mainly in the medial layer, sug-
gesting impaired mechanical support and emphasiz-
ing the significant role of type III collagen in AAAs.
Type I pN-collagen, in turn, was only present in the
intima, where the atherosclerotic lesion develops.
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